ASIAN OCEANIAN SOCIETY of NEUROPATHOLOGY
The Asian Oceanian Society of Neuropathology (AOSNP) originated in 2007 as the Asian Society of Neuropathology (ASNP). In 2018, at the General Assembly meeting of the 4th Congress of the Asian Society of Neuropathology held in Tokyo, Japan, it was proposed to include Oceanian countries, leading to the transformation of ASNP to AOSNP.
The formation of the AOSNP was officially finalised on September 25, 2021, in the Executive meeting of the 5th Congress held in Bengaluru, India with participation of members from Japan, India, China, Australia, New Zealand, Hong Kong, Korea, Jordan, Turkey, Malaysia and Philippines. The formation of the new society was subsequently reported to the International Society of Neuropathology (ISN) and published on the ISN website.
Aims
The AOSNP is a 'not for profit' organization that aims to achieve the following in the Asian Oceanian region:
- Enhance the quality of practice of Neuropathology.
- Promote its development and advancement as a subspecialty.
- Endorse collaboration and exchange of knowledge.
- Encourage educational activities and research in neuropathology and allied disciplines.
Mission
To advance knowledge in the field of Neuropathology, and to disseminate such knowledge in the Asian Oceanian Region.
ACTIVITIES OF THE SOCIETY
- AOSNP-ADAPTR initiative (Adapting Diagnostic Approaches for Practical Taxonomy in Resource-Restrained Regions)
- Joint Neuropathology Workshops of Asian Society of Neuro - Oncology (ASNO) with AOSNP
- Asian Oceanian Congress of Neuropathology (AOCN)
It is both a profound honour and a great privilege for me to serve as the President of the Asian Oceanian Society of Neuropathology (AOSNP), and I extend my heartfelt gratitude to all members for entrusting me with this....
Message from the Past PresidentChitra Sarkar
Past President
AOSNP
President's Message
Presidents message for AOSNP website
December 2025
I believe that by working across multiple countries within Asia and Oceania, incorporating many inputs and varying perspectives, whilst engaging in important medical problems of our time, we, as neuropathologists can play an important role in improving patient care. Stroke and neurodegenerative diseases are common causes of death in the elderly with considerable social and financial implications. Many brain tumours, across an age spectrum, remain incurable, and most muscular dystrophies have long term medical and social consequences with limited specific treatment options. Infectious diseases of the central nervous system across our lands also provide scope for us to educate the rest of the world.
As neuropathologists, we play a pivotal role in diagnosing and helping to understand these diseases. Diagnostic criteria for all diseases of nerve, brain and muscle need to be optimised for a breadth of resource settings in our vast populations. We need to work with our fellow pathologists and educate all those with an interest in neuropathology. By collaborating with and educating our associated clinicians such as neurologists, neurooncologists, and neurosurgeons, this too will improve patient care.
So, let us all work together in our fascinating field of neuropathology. We have a unique opportunity to add to the world's knowledge base due to our varied and large population.
Professor Catriona McLean AO
BSc, MBBS, FRCPA, FFSc, FAAHMS
President AOSNP
Message from Secretary General
Dear Colleagues,
I am pleased to convey this message on behalf of the Asian Oceanian Society of Neuropathology (AOSNP). The formation of AOSNP represents a significant advancement for our region, uniting neuropathologists, neuroscientists, and allied professionals committed to progress in our discipline.
Our objective is to develop an inclusive and dynamic platform that facilitates scientific exchange, enhances education and training, and promotes collaboration across Asia and Oceania. By leveraging the diverse expertise and perspectives of our members, we aspire to elevate standards in neuropathology, foster impactful research, and make meaningful contributions to patient care throughout the region.
The strength of our society resides in the collective knowledge, dedication, and vision of its members. Among our notable accomplishments is the AOSNP-ADAPTR initiative, translating WHO CNS5 guidelines for central nervous system tumors into practical diagnostic pathways tailored for low-resource settings. This effort exemplifies our commitment to equitable healthcare by ensuring access to accurate, high-quality neuropathological diagnosis irrespective of geography or economic status.
Our goals encompass not only neurooncological conditions but also prevalent neurological disorders in our region, including infectious, inflammatory, metabolic, nutritional, neuromuscular diseases, stroke, and dementia. Multi-institutional partnerships, regional registries, and context-driven research will be fundamental to advancing understanding and improving patient outcomes.
As we embark on this important journey, I encourage you to participate in our society’s initiatives, contribute your expertise, and help shape the future direction of our organization. Your involvement is vital to building a strong and progressive society that exemplifies scientific excellence and professional collaboration within our region.
I look forward to working with each of you as we advance the field of neuropathology together.
Sincerely,
Vani Santosh
Secretary General
Asian Oceanian Society of Neuropathology
List of Participating Countries in AOSNP
| India | Japan |
| Indonesia | China |
| Malaysia | Turkey |
| Philippines | Jordan |
| Thailand | Australia |
| Singapore | New Zealand |
| Korea | Taiwan |
| Bangladesh | Sri Lanka |
| Nepal | Pakistan |
| Vietnam |